These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 25081290

  • 1. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
    Murray CD, Wood D, Allgar V, Walters G, Gale RP.
    Eye (Lond); 2014 Oct; 28(10):1218-22. PubMed ID: 25081290
    [Abstract] [Full Text] [Related]

  • 2. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP, Haji SA, Frenkel RE.
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.
    Felfeli T, Hostovsky A, Trussart R, Yan P, Brent MH, Mandelcorn ED.
    Br J Ophthalmol; 2019 Oct; 103(10):1388-1394. PubMed ID: 30573499
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection.
    El Chehab H, Le Corre A, Agard E, Ract-Madoux G, Coste O, Dot C.
    Eur J Ophthalmol; 2013 Oct; 23(3):277-83. PubMed ID: 23161177
    [Abstract] [Full Text] [Related]

  • 10. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV, Tsuang AJ, Gelman R, Mendonca LS, Della Torre KE, Jung JJ, Freund KB.
    Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis).
    Sharei V, Höhn F, Köhler T, Hattenbach LO, Mirshahi A.
    Eur J Ophthalmol; 2010 Jan; 20(1):174-9. PubMed ID: 19927267
    [Abstract] [Full Text] [Related]

  • 13. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.
    Kim JE, Mantravadi AV, Hur EY, Covert DJ.
    Am J Ophthalmol; 2008 Dec; 146(6):930-4.e1. PubMed ID: 18775528
    [Abstract] [Full Text] [Related]

  • 14. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration.
    Mathalone N, Arodi-Golan A, Sar S, Wolfson Y, Shalem M, Lavi I, Geyer O.
    Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1435-40. PubMed ID: 22434210
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.
    Wehrli SJ, Tawse K, Levin MH, Zaidi A, Pistilli M, Brucker AJ.
    Retina; 2012 Jul; 32(7):1295-301. PubMed ID: 22466465
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
    El Chehab H, Le Corre A, Giraud JM, Ract-Madoux G, Swalduz B, Dot C.
    J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of multiple intravitreal antivascular endothelial growth factor injections on intraocular pressure.
    Kim YJ, Sung KR, Lee KS, Joe SG, Lee JY, Kim JG, Yoon YH.
    Am J Ophthalmol; 2014 Jun; 157(6):1266-1271.e1. PubMed ID: 24561173
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.
    Hoang QV, Mendonca LS, Della Torre KE, Jung JJ, Tsuang AJ, Freund KB.
    Ophthalmology; 2012 Feb; 119(2):321-6. PubMed ID: 22054994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.